Published in Cardiovascular Week, September 3rd, 2007
With over 20 years of experience on the forefront of artificial organs and circulatory care, and heading the world's most active ventricular assist device program (VAD), Dr. Banayosy is a widely published, internationally renowned expert and lecturer in the treatment of heart and organ failure.
"I'm honored to welcome Dr. Banayosy to the HepaLife team," stated Mr. Frank Menzler, President and CEO of HepaLife Technologies, Inc....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
Source: Cardiovascular Week (2007-09-03)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.